Novartis AG (NVS)
131.08
+0.07
(+0.05%)
USD |
NYSE |
Dec 10, 13:43
Novartis Total Assets (Quarterly): 107.29B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Roche Holding AG | -- |
| Regeneron Pharmaceuticals, Inc. | 40.17B |
| Avidity Biosciences, Inc. | 2.134B |
| Monte Rosa Therapeutics, Inc. | 459.84M |
| Tourmaline Bio, Inc. | 269.30M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 62.54B |
| Shareholders Equity (Quarterly) | 44.33B |
| Debt to Equity Ratio | 0.7224 |
| Current Ratio | 0.8812 |
| Net Debt Paydown Yield | -0.25% |